Overview

Valbenazine in Obsessive Compulsive Disorder

Status:
NOT_YET_RECRUITING

Trial end date:
2027-10-01

Target enrollment:

Participant gender:

Summary

The primary aim of the study is to examine the efficacy and safety of valbenazine in adults with moderate to severe obsessive-compulsive disorder (OCD).

Phase:

PHASE2

Details

Lead Sponsor:

University of Chicago

Collaborator:

Neurocrine Biosciences

Treatments:

valbenazine